Cargando…
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
BACKGROUND: Although women account for a growing proportion of the oncology workforce, there is evidence they are under-represented in leadership roles. To gain further insights into this issue and extend understanding of gender challenges, the European Society for Medical Oncology Women for Oncolog...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157518/ https://www.ncbi.nlm.nih.gov/pubmed/30273420 http://dx.doi.org/10.1136/esmoopen-2018-000422 |
_version_ | 1783358281173958656 |
---|---|
author | Banerjee, Susana Dafni, Urania Allen, Tamara Arnold, Dirk Curigliano, Giuseppe Garralda, Elena Garassino, Marina Chiara Haanen, John Hofstädter-Thalmann, Eva Robert, Caroline Sessa, Cristiana Tsourti, Zoi Zygoura, Panagiota Peters, Solange |
author_facet | Banerjee, Susana Dafni, Urania Allen, Tamara Arnold, Dirk Curigliano, Giuseppe Garralda, Elena Garassino, Marina Chiara Haanen, John Hofstädter-Thalmann, Eva Robert, Caroline Sessa, Cristiana Tsourti, Zoi Zygoura, Panagiota Peters, Solange |
author_sort | Banerjee, Susana |
collection | PubMed |
description | BACKGROUND: Although women account for a growing proportion of the oncology workforce, there is evidence they are under-represented in leadership roles. To gain further insights into this issue and extend understanding of gender challenges, the European Society for Medical Oncology Women for Oncology (W4O) Committee undertook a survey of female and male oncologists in 2016. DESIGN: The 2016 W4O questionnaire included questions on (1) Demographics and professional environment, (2) Gender impact on career development, (3) Challenges for career progression and inappropriate behaviour experienced in the workplace, (4) Barriers for gender parity and (5) The gender gap. Between July and September 2016, the online survey was available to male and female clinical and academic oncology healthcare professionals in the EU and internationally. RESULTS: Responses were analysed from 462 oncologists, of whom 76.7 % were women. Of female respondents, 45.5 % had a managerial or leadership role, compared with 65 % of male respondents (p<0.001). Men were more likely to have leadership roles, even in clinical teams with more women than men. Women respondents were more likely to consider their gender had a major impact on their career than men: 35.9 % vs 20.9 % (p<0.001). The biggest challenge to career progression for women was work and family balance (64.2%). Of female respondents, 14.4 % believed there had been significant or major progress in closing the gender pay gap compared with 39.3 % of men (p<0.001). Of female participants, 37.7 % reported they had encountered unwanted sexual comments by a superior or colleague. CONCLUSIONS: New initiatives are needed to address under-representation of women oncologists in leadership roles, including greater and concrete promotion of work–life balance, development and leadership training for women, and more support for flexible working. The fact that over a third of women in the survey had encountered unwanted sexual comments at work is of great concern and must be urgently addressed. |
format | Online Article Text |
id | pubmed-6157518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-61575182018-09-28 Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey Banerjee, Susana Dafni, Urania Allen, Tamara Arnold, Dirk Curigliano, Giuseppe Garralda, Elena Garassino, Marina Chiara Haanen, John Hofstädter-Thalmann, Eva Robert, Caroline Sessa, Cristiana Tsourti, Zoi Zygoura, Panagiota Peters, Solange ESMO Open Original Research BACKGROUND: Although women account for a growing proportion of the oncology workforce, there is evidence they are under-represented in leadership roles. To gain further insights into this issue and extend understanding of gender challenges, the European Society for Medical Oncology Women for Oncology (W4O) Committee undertook a survey of female and male oncologists in 2016. DESIGN: The 2016 W4O questionnaire included questions on (1) Demographics and professional environment, (2) Gender impact on career development, (3) Challenges for career progression and inappropriate behaviour experienced in the workplace, (4) Barriers for gender parity and (5) The gender gap. Between July and September 2016, the online survey was available to male and female clinical and academic oncology healthcare professionals in the EU and internationally. RESULTS: Responses were analysed from 462 oncologists, of whom 76.7 % were women. Of female respondents, 45.5 % had a managerial or leadership role, compared with 65 % of male respondents (p<0.001). Men were more likely to have leadership roles, even in clinical teams with more women than men. Women respondents were more likely to consider their gender had a major impact on their career than men: 35.9 % vs 20.9 % (p<0.001). The biggest challenge to career progression for women was work and family balance (64.2%). Of female respondents, 14.4 % believed there had been significant or major progress in closing the gender pay gap compared with 39.3 % of men (p<0.001). Of female participants, 37.7 % reported they had encountered unwanted sexual comments by a superior or colleague. CONCLUSIONS: New initiatives are needed to address under-representation of women oncologists in leadership roles, including greater and concrete promotion of work–life balance, development and leadership training for women, and more support for flexible working. The fact that over a third of women in the survey had encountered unwanted sexual comments at work is of great concern and must be urgently addressed. BMJ Publishing Group 2018-09-21 /pmc/articles/PMC6157518/ /pubmed/30273420 http://dx.doi.org/10.1136/esmoopen-2018-000422 Text en © Author (s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Original Research Banerjee, Susana Dafni, Urania Allen, Tamara Arnold, Dirk Curigliano, Giuseppe Garralda, Elena Garassino, Marina Chiara Haanen, John Hofstädter-Thalmann, Eva Robert, Caroline Sessa, Cristiana Tsourti, Zoi Zygoura, Panagiota Peters, Solange Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey |
title | Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey |
title_full | Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey |
title_fullStr | Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey |
title_full_unstemmed | Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey |
title_short | Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey |
title_sort | gender-related challenges facing oncologists: the results of the esmo women for oncology committee survey |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157518/ https://www.ncbi.nlm.nih.gov/pubmed/30273420 http://dx.doi.org/10.1136/esmoopen-2018-000422 |
work_keys_str_mv | AT banerjeesusana genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT dafniurania genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT allentamara genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT arnolddirk genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT curiglianogiuseppe genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT garraldaelena genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT garassinomarinachiara genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT haanenjohn genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT hofstadterthalmanneva genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT robertcaroline genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT sessacristiana genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT tsourtizoi genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT zygourapanagiota genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey AT peterssolange genderrelatedchallengesfacingoncologiststheresultsoftheesmowomenforoncologycommitteesurvey |